Digipharm- Destined to take healthcare to next level

There has been one industry that has relentlessly performed for the betterment and welfare of mankind – the health care industry. No matter what, this industry has always delivered and met the expectations of the end users. Moreover, it has been profitable too and that is the reason why it has survived the worst phase of the economic downturn, when the rest of the industries were struggling to cope up with the economic slowdown. But, there has been a change in the trend. Health care is now into money making business and consumers in the form of patients are being exploited. Humans are toiling at the receiving end of this phase. There has to be mutual prosperity if a business has to flourish. The value that the consumers expects from healthcare is missing. To fill this gap and offer a value driven health care services Digipharm has taken the initiative and it is just the beginning of a revolution.

Introduction

Digipharm is a blockchain chain-based platform that aims to accelerate the much-needed restructuring of healthcare delivery systems to a value-based approach. There are deep rooted flaws in the present healthcare infrastructure world- wide which results in considerable inefficiency, wastage and below standard health outcomes for the patients. Today, there is a shortage of incentive for health systems and providers to focus on mutually beneficial goals and better results for patients. Digipharm aim is to overcome all these barriers through technology. It will bypass all the infrastructural limitations to drive value improvement, incentivise innovation and accelerate the transformation to personalized healthcare. There will be open access for patient, innovative pricing and ultimately a reduced cost for all the stake holders. Thus, the vision of becoming "the pioneer of value-based healthcare delivery, generation of innovative evidence and empowerment of patient across the healthcare industry" will be achieved.

Industry Problems

Healthcare systems face an uphill task of deciding whether to reimburse costly

pharmacological therapies and provide access for patients while taking into account their limited resources. There is an acute shortage of adequate infrastructure to track and implement innovative pricing models such as value-based pricing agreements This results in new pharmacological therapies being denied to patients who are most at need. Though real -world evidence(RWE) is an important tool in healthcare industry, but the delay in RWE outputs, the expenses of data access and the current methods of data collection negate many of the benefits of utilising these rich data resources. The stakeholders cannot evaluate the real time performance and value provided by various therapies.

Solutions

Digipharm will remove the infrastructural barriers through the automation and implementation of innovative value-based pricing agreements on a fully independent platform. It will provide personalized reimbursement of health technology on a fee for performance basis which will mutually benefit the patients, payers and manufacturers. To solve the existing flaws in RWE, it will develop the world's first live RWE platform. Health related research, decision making and to incentivisation of patients to contribute their data can be easily carried out through utilization of real world data(RWD).

Token Details

Digipharm tokens are called as DPH tokens which operates on Ethereum ERC-20 platform. There will be a total supply of 100,000,000 DPH tokens. The token price is 1.00 USD. In the pre- sale 15,000,000 DPH will be issued at a base price of 1.00 USD. THE pre -sale length is 4 weeks it offers a discount of 35%. In the main sale 50,000,000 DPH will be issued. In case token are unsold, it will be burnt.

Conclusion

Digipharm is one of a kind healthcare block chain technology enabled platform which is bound to bring a revolution in healthcare industry. It is going to be a disruptor in the entire healthcare industry. Right from innovative pricing to real time Real World Experience(RWD) and what not, this is a cutting edge, technologically superior platform where patients are given due values on their services. The most important stake holders that is the patients are going to receive best of the best services at utmost satisfaction. It is a win-win situation for both customers and the company. With this unique and innovative platform, investors can bet high on this with exceedingly high returns. It is the time to take healthcare to next level where experience exceeds expectations.

Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf

Author: Yalsik S
Profile: https://bitcointalk.org/index.php?action=profile;u=1943321